Rafferty Asset Management, LLC Zentalis Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.09 - $16.13 $533,515 - $2.1 Million	-130,444 Reduced 43.77%	167,564 $685,000
Q1 2024 May 13, 2024	SELL	$10.83 - $16.49 $672,727 - $1.02 Million	-62,117 Reduced 17.25%	298,008 $4.7 Million
Q4 2023 Feb 13, 2024	BUY	$9.84 - $20.13 $1.57 Million - $3.21 Million	159,439 Added 79.45%	360,125 $5.46 Million
Q3 2023 Nov 13, 2023	SELL	$19.63 - $28.29 $986,819 - $1.42 Million	-50,271 Reduced 20.03%	200,686 $4.03 Million
Q2 2023 Aug 11, 2023	BUY	$17.41 - $30.05 $731,898 - $1.26 Million	42,039 Added 20.12%	250,957 $7.08 Million
Q1 2023 May 11, 2023	SELL	$16.14 - $24.94 $329,740 - $509,524	-20,430 Reduced 8.91%	208,918 $3.59 Million
Q4 2022 Feb 13, 2023	BUY	$18.07 - $25.6 $823,323 - $1.17 Million	45,563 Added 24.79%	229,348 $4.62 Million
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $1.18 Million - $1.86 Million	58,538 Added 46.74%	183,785 $3.98 Million
Q2 2022 Aug 12, 2022	BUY	$17.91 - $52.25 $73,019 - $213,023	4,077 Added 3.36%	125,247 $3.52 Million
Q1 2022 May 13, 2022	BUY	$41.58 - $80.89 $2.33 Million - $4.53 Million	55,971 Added 85.85%	121,170 $5.59 Million
Q4 2021 Feb 10, 2022	BUY	$66.92 - $84.79 $1.85 Million - $2.34 Million	27,611 Added 73.46%	65,199 $5.48 Million
Q3 2021 Nov 10, 2021	SELL	$46.83 - $73.5 $414,913 - $651,210	-8,860 Reduced 19.08%	37,588 $2.51 Million
Q2 2021 Aug 10, 2021	SELL	$37.41 - $62.25 $713,707 - $1.19 Million	-19,078 Reduced 29.12%	46,448 $2.47 Million
Q1 2021 May 10, 2021	BUY	$35.69 - $52.72 $2.12 Million - $3.13 Million	59,373 Added 964.94%	65,526 $2.84 Million
Q4 2020 Feb 10, 2021	BUY	$31.71 - $57.97 $195,111 - $356,689	6,153 New	6,153 $320,000

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

Matrix Capital Management Company, LP Waltham, MA

14M
Shares

$41.9 Million
2.45% of portfolio
Eventide Asset Management, LLC Boston, MA

8.55M
Shares

$25.6 Million
0.55% of portfolio
Black Rock Inc. New York, NY

4.82M
Shares

$14.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.61M
Shares

$13.8 Million
0.0% of portfolio
Decheng Capital LLC Menlo Park, CA

3.11M
Shares

$9.32 Million
2.71% of portfolio

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account